Clinical trial updates

December 22, 2023

SP-420

Read More »
August 21, 2023

CASGEVY™ (gene editing)

Read More »
August 21, 2023

INTERCEPT™ (pathogen inactivation)

Read More »
August 20, 2023

Hemanext ONE®

Read More »
August 20, 2023

Ferriprox®

Read More »
August 20, 2023

ST-400 (gene editing)

Read More »
August 20, 2023

reni-cel (EDIT-301)

Read More »
August 20, 2023

Reblozyl®

Update: 30 June 2024 The study is staggered and in 2 parts: Part A (patients 12 – 17 years old) Part B (patients 6 – 12 years old) Part B…
Read More »
August 18, 2023

ZYNTEGLO™ (gene therapy)

Read More »
August 17, 2023

MWTX-003

Read More »